NO954781D0 - Fremgangsmåter for screening av substanser med en modulerende virkning på en interleukin-5-reseptoravhengig cellulær signaloverföringsvei - Google Patents

Fremgangsmåter for screening av substanser med en modulerende virkning på en interleukin-5-reseptoravhengig cellulær signaloverföringsvei

Info

Publication number
NO954781D0
NO954781D0 NO954781A NO954781A NO954781D0 NO 954781 D0 NO954781 D0 NO 954781D0 NO 954781 A NO954781 A NO 954781A NO 954781 A NO954781 A NO 954781A NO 954781 D0 NO954781 D0 NO 954781D0
Authority
NO
Norway
Prior art keywords
receptor
signal transmission
interleukine
pct
interleukin
Prior art date
Application number
NO954781A
Other languages
English (en)
Other versions
NO316027B1 (no
NO954781L (no
Inventor
Armin Peter Czernilofsky
Ulrike Weyer
Ian G Young
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO954781D0 publication Critical patent/NO954781D0/no
Publication of NO954781L publication Critical patent/NO954781L/no
Publication of NO316027B1 publication Critical patent/NO316027B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19954781A 1993-05-27 1995-11-24 Fremgangsmåter for screening av substanser med en modulerende virkning på en interleukin-5-reseptoravhengig cellul¶r signaloverföringsvei,samt pattedyrceller NO316027B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4317577A DE4317577A1 (de) 1993-05-27 1993-05-27 Verfahren zum Screenen von Substanzen mit modulierender Wirkung auf einen Interleukin-5-Rezeptor-abhängigen zellulären Signalübertragungsweg
PCT/EP1994/001735 WO1994028170A1 (de) 1993-05-27 1994-05-27 Verfahren zum screenen von substanzen mit modulierender wirkung auf einen interleukin-5-rezeptor-abhängigen zellulären signalübertragungsweg

Publications (3)

Publication Number Publication Date
NO954781D0 true NO954781D0 (no) 1995-11-24
NO954781L NO954781L (no) 1996-01-23
NO316027B1 NO316027B1 (no) 2003-12-01

Family

ID=6488996

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19954781A NO316027B1 (no) 1993-05-27 1995-11-24 Fremgangsmåter for screening av substanser med en modulerende virkning på en interleukin-5-reseptoravhengig cellul¶r signaloverföringsvei,samt pattedyrceller

Country Status (17)

Country Link
US (1) US5922549A (no)
EP (1) EP0701628B1 (no)
JP (1) JPH08510643A (no)
KR (1) KR100318188B1 (no)
CN (1) CN1125467A (no)
AT (1) ATE162555T1 (no)
AU (1) AU691816B2 (no)
CA (1) CA2163549A1 (no)
DE (2) DE4317577A1 (no)
DK (1) DK0701628T3 (no)
ES (1) ES2113109T3 (no)
FI (1) FI111016B (no)
HU (1) HU220345B (no)
NO (1) NO316027B1 (no)
NZ (1) NZ291131A (no)
RU (1) RU2139936C1 (no)
WO (1) WO1994028170A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405350D0 (en) * 1994-03-18 1994-05-04 Sandoz Ltd Organic compounds
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
AU2001296607A1 (en) * 2000-10-03 2002-04-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education High efficiency regulatable gene expression system
WO2004042007A2 (en) * 2002-10-30 2004-05-21 University Of Iowa Research Foundation Somatic cell gene targeting vectors and methods of use thereof
WO2004092402A1 (en) * 2003-04-15 2004-10-28 Pfizer Inc. Dual reporter/dye reduction methodology for evaluating antiviral activity and cytotoxicity of hepatitis c virus inhibitors
US20050112551A1 (en) * 2003-11-24 2005-05-26 Agouron Pharmaceuticals, Inc. Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor
WO1992013063A1 (en) * 1991-01-18 1992-08-06 Oncogene Science, Inc. Methods of transcriptionally modulating expression of growth factor genes and growth factor receptor genes
EP0668930B1 (en) * 1991-10-01 2002-12-18 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES A method of identifying ligands and antagonists of ligands

Also Published As

Publication number Publication date
EP0701628A1 (de) 1996-03-20
HUT73742A (en) 1996-09-30
US5922549A (en) 1999-07-13
WO1994028170A1 (de) 1994-12-08
KR960702532A (ko) 1996-04-27
KR100318188B1 (ko) 2002-06-20
RU2139936C1 (ru) 1999-10-20
CA2163549A1 (en) 1994-12-08
FI111016B (fi) 2003-05-15
NZ291131A (en) 1996-10-28
NO316027B1 (no) 2003-12-01
HU220345B (hu) 2001-12-28
FI955700A0 (fi) 1995-11-27
ES2113109T3 (es) 1998-04-16
NO954781L (no) 1996-01-23
DK0701628T3 (da) 1998-09-21
AU691816B2 (en) 1998-05-28
AU6997794A (en) 1994-12-20
DE59405120D1 (de) 1998-02-26
ATE162555T1 (de) 1998-02-15
FI955700A (fi) 1995-11-27
DE4317577A1 (de) 1994-12-01
JPH08510643A (ja) 1996-11-12
HU9503363D0 (en) 1996-01-29
EP0701628B1 (de) 1998-01-21
CN1125467A (zh) 1996-06-26

Similar Documents

Publication Publication Date Title
AU2945592A (en) Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path
Romey et al. The coexistence in rat muscle cells of two distinct classes of Ca2+-dependent K+ channels with different pharmacological properties and different physiological functions
Atanasiu et al. Regulation of herpes simplex virus gB-induced cell-cell fusion by mutant forms of gH/gL in the absence of gD and cellular receptors
ATE171472T1 (de) Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4
ZA877719B (en) Immunoassay based on two enzyme inhibition system
NO954781D0 (no) Fremgangsmåter for screening av substanser med en modulerende virkning på en interleukin-5-reseptoravhengig cellulær signaloverföringsvei
DE69126526D1 (de) Verfahren zur zellwachstumshinderung und dazu nützliche verbindungen
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
CA2057854A1 (en) Pdgf .alpha.-receptor
ATE377073T1 (de) Modulatoren der funktion des fas/ap01 rezeptors
Chen et al. Enhancement of presynaptic calcium current by cysteine string protein
ES2161245T3 (es) Gen marcador.
ATE415487T1 (de) Biologisches testverfahren für thyroid stimulierende antikörper
Hauser et al. Optimized quantification of lymphocyte subsets by use of CD7 and CD33
Owe‐Larsson et al. Distinct effects of clostridial toxins on activity‐dependent modulation of autaptic responses in cultured hippocampal neurons
CY1109289T1 (el) Αλληλεπιδραση κινασων μεκκ1 σερινης θρεονινης με το σχετιζομενο με το fha forkhead πεδιο της πρωτεϊνης 1 (mif 1)
ES2170937T3 (es) Agentes de reticulacion bis-maleimido.
Scott et al. Standardization of papain reagents by measurement of active sites using a synthetic inhibitor, E‐64
DE69333364T2 (de) REKOMBINANTES CDw52 ANTIGEN
ES2178517A1 (es) Procedimiento para el estudio de la activacion funcional de leucocitos, plaquetas y otras celulas.
Barkeby International seismological data center. Input data for an experimental data base
Soo RAPID INHIBITION OF COLLAGEN SYNTHESIS AFTER TRANSFORMATION OF AVIAN TENDON CELLS BY A TEMPERATURE-SENSITIVE MUTANT OF ROUS SARCOMA VIRUS
NO950726L (no) Nukleær levering av makromolekyler med translokasjonssignal

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees